Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
Joshua D. Lee, MD, MSc1,2; Mia Malone, BA1; Ryan McDonald, MA1; et alAnna Cheng, BA1; Kumar Vasudevan, MD1,2; Babak Tofighi, MD1,2; Ann Garment, MD2; Barbara Porter, MD2; Keith S. Goldfeld, DrPH1; Michael Matteo3; Jasdeep Mangat, MD3; Monica Katyal, JD, MPH3; Jonathan Giftos, MD3; Ross MacDonald, MD2,3 Author Affiliations Article Information JAMA Netw Open. 2021;4(9):e2123032. doi:10.1001/jamanetworkopen.2021.23032 Key Points Question Is extended-release buprenorphine an acceptable and helpful jail-to-community treatment [...]